关于老年糖尿病患者血糖超出范围的人群健康安全 measure 的提案
研究评估了针对高危老年糖尿病患者提出的超出范围(OOR)血糖 measure(过度治疗 OT:HbA1c<7% [53 mmol/mol] 或治疗不足 UT:>9% [75 mmol/mol])与标准 measure(SM:HbA1c<8% [64 mmol/mol])在患者层面血糖控制和机构差异上的表现。共纳入193,689例至少有一种显著内科、神经或心理健康状况的患者,98.2%使用磺脲类和/或胰岛素。基于SM和OOR的机构排名存在显著差异,OOR measure可将质量改进聚焦于个体患者评估以减少短期伤害风险。
要点
- 65-75岁患者中47.4%符合OOR(33.4% OT,14% UT),65.7%符合SM
- >75岁患者中48.1%符合OOR(39.2% OT,8.9% UT),73.2%符合SM
- SM与OOR机构排名呈强负相关(ρ=-0.41),最佳SM机构中14/28在OOR上排名最差20%
核心结论
- 基于SM(潜在获益)和OOR measure(潜在风险)的机构排名存在显著差异。
- 针对高危人群的OOR可将质量改进聚焦于个体患者评估,以减少短期伤害风险。
研究设计与样本
- 研究识别了2012年年龄≥65岁、2013年使用抗高血糖药物的退伍军人健康管理局患者。
- 按年龄和共病负担计算患者层面比率和机构层面比率/排名。
- 共识别303,097例使用除二甲双胍外抗血糖药物的患者;研究人群包括193,689例至少有一种显著内科、神经或心理健康状况的患者。
主要发现
- 98.2%的患者使用磺脲类和/或胰岛素;55.2%年龄65-75岁,44.8%年龄>75岁。
- 65-75岁患者中47.4%符合OOR measure(33.4% OT,14% UT),65.7%符合SM。
- >75岁患者中OOR率为48.1%(39.2% OT;8.9% UT),SM率为73.2%。
- 65-75岁患者机构层面OOR率范围为33.7%至60.4%(中位数47.4%),SM与OOR绩效排名之间呈强负相关(ρ=-0.41)。
- SM表现最佳20%的机构中,14/28在OOR measure上排名最差20%;SM表现最差20%的机构中,12/27在OOR measure上排名最佳20%。
关键数值与推荐
- OOR measure定义为过度治疗(OT)HbA1c<7%(53 mmol/mol)或治疗不足(UT)HbA1c>9%(75 mmol/mol)。
- 标准 measure(SM)定义为HbA1c<8%(64 mmol/mol)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate patient-level glycemic control and facility variation of a proposed out-of-range (OOR) measure (overtreatment [OT] [HbA1c <7% (53 mmol/mol)] or undertreatment [UT] [>9% (75 mmol/mol)]) compared with the standard measure (SM) (HbA1c <8% [64 mmol/mol]) in high-risk older adults. RESEARCH DESIGN AND METHODS: Veterans Health Administration patients ≥65 years of age in 2012 who were taking antihyperglycemic agents in 2013 were identified. Patient-level rates and facility-level rates/rankings were calculated by age and comorbid illness burden. RESULTS: We identified 303,097 patients who were taking antiglycemic agents other than metformin only. The study population comprised 193,689 patients with at least one significant medical, neurological, or mental health condition; 98.2% were taking a sulfonylurea and/or insulin; 55.2% were aged 65-75 years; and 44.8% were aged >75 years. The 47.4% of patients 65-75 years met the OOR measure (33.4% OT, 14% UT), and 65.7% met the SM. For patients aged >75 years, rates were 48.1% for OOR (39.2% OT; 8.9% UT) and 73.2% for SM. Facility-level rates for OOR for patients aged 65-75 years ranged from 33.7 to 60.4% (median 47.4%), with a strong inverse correlation (ρ = -0.41) between SM and OOR performance rankings. Among the best-performing 20% facilities on the SM, 14 of 28 ranked in the worst-performing 20% on the OOR measure; 12 of 27 of the worst-performing 20% facilities on the SM ranked in the best-performing 20% on the OOR measure. CONCLUSIONS: Facility rankings that are based on an SM (potential benefits) and OOR measure (potential risks) differ substantially. An OOR for high-risk populations can focus quality improvement on individual patient evaluation to reduce the risk for short-term harms.
引用
- Pogach L, Tseng CL, Soroka O, et al. A Proposal for an Out-of-Range Glycemic Population Health Safety Measure for Older Adults With Diabetes. Diabetes Care. 2016. PMID: 28325799. doi:10.2337/dc16-0953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。